CIP
INSP icon

Champlain Investment Partners’s Inspire Medical Systems INSP Stock Holding History

Champlain Investment Partners’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-158,989
Closed -$8.2M – 132
2026
Q1 		$8.2M Sell
158,989
-44,109
-22% -$3.09M 0.1% 127
2025
Q4 		$18.7M Sell
203,098
-203,961
-50% -$19.5M 0.19% 120
2025
Q3 		$30.2M Sell
407,059
-5,047
-1% -$511K 0.23% 127
2025
Q2 		$53.5M Sell
412,106
-23,656
-5% -$3.43M 0.37% 105
2025
Q1 		$69.4M Sell
435,762
-8,647
-2% -$1.56M 0.5% 84
2024
Q4 		$82.4M Sell
444,409
-20,203
-4% -$3.92M 0.52% 81
2024
Q3 		$98.1M Sell
464,612
-50,173
-10% -$8.72M 0.59% 73
2024
Q2 		$68.9M Sell
514,785
-126,900
-20% -$24M 0.42% 91
2024
Q1 		$138M Sell
641,685
-6,910
-1% -$1.35M 0.79% 47
2023
Q4 		$132M Buy
648,595
+179,050
+38% +$29M 0.78% 55
2023
Q3 		$93.2M Sell
469,545
-96,570
-17% -$24.4M 0.6% 67
2023
Q2 		$184M Sell
566,115
-90,210
-14% -$25.8M 1.13% 29
2023
Q1 		$154M Sell
656,325
-11,930
-2% -$3.02M 0.97% 35
2022
Q4 		$168M Sell
668,255
-21,915
-3% -$4.67M 1.08% 27
2022
Q3 		$122M Sell
690,170
-8,415
-1% -$1.69M 0.84% 49
2022
Q2 		$128M Sell
698,585
-4,070
-0.6% -$812K 0.82% 48
2022
Q1 		$180M Buy
702,655
+29,930
+4% +$6.84M 0.93% 41
2021
Q4 		$155M Buy
672,725
+3,345
+0.5% +$817K 0.7% 61
2021
Q3 		$156M Buy
669,380
+7,725
+1% +$1.61M 0.75% 56
2021
Q2 		$128M Buy
661,655
+66,315
+11% +$13.2M 0.61% 74
2021
Q1 		$123M Buy
595,340
+14,680
+3% +$3.12M 0.64% 72
2020
Q4 		$109M Sell
580,660
-306,790
-35% -$50.2M 0.63% 70
2020
Q3 		$115M Sell
887,450
-35,730
-4% -$3.94M 0.78% 54
2020
Q2 		$80.3M Buy
923,180
+52,860
+6% +$4.06M 0.58% 69
2020
Q1 		$52.5M Buy
870,320
+207,355
+31% +$15.3M 0.47% 79
2019
Q4 		$49.2M Buy
662,965
+366,575
+124% +$23.6M 0.36% 96
2019
Q3 		$18.1M Buy
+296,390
New +$19.5M 0.15% 110

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Champlain Investment Partners's INSP Position: Q2 2026 in Review

Champlain Investment Partners sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 158,989 shares — an estimated $8.2M sold.

Champlain Investment Partners first reported a position in INSP in Q3 2019 and held it in 27 quarters. The position peaked at $184M in Q2 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Champlain Investment Partners reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Champlain Investment Partners sold 158,989 Inspire Medical Systems shares in Q2 2026, an estimated $8.2M.
  • Champlain Investment Partners first reported a position in Inspire Medical Systems in Q3 2019 and held it in 27 quarters.
  • Champlain Investment Partners's Inspire Medical Systems position peaked at $184M in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.